Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease

Forty-eight weeks of therapy with an active vitamin D analog reduces LAVi and attenuates the rise of BNP. In a population where only few therapies alter cardiovascular related morbidity and mortality, these post hoc results warrant further confirmation.